Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (47)

2024

  1. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease

    BMJ Open, Vol. 14, Núm. 4

2023

  1. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

    Cochrane Database of Systematic Reviews, Vol. 2023, Núm. 3

  2. Factors associated with salbutamol overuse in bronchiolitis

    European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 4237-4245

  3. Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis

    Archives of Gynecology and Obstetrics, Vol. 308, Núm. 2, pp. 363-377

2022

  1. Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care

    Frontiers in Medicine, Vol. 9

  2. Corrigendum: Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors, (Front. Cardiovasc. Med, (2022), 9, (827212), 10.3389/fcvm.2022.827212)

    Frontiers in Cardiovascular Medicine

  3. Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors

    Frontiers in Cardiovascular Medicine, Vol. 9

  4. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  5. Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain

    F1000Research, Vol. 10

  6. Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 659-668

  7. Risk and Mortality Factors for Pleural Effusions Requiring Diagnostic Thoracentesis

    Open Respiratory Archives, Vol. 4, Núm. 4

  8. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1

2021

  1. Appropriateness of surgery performed for abdominal aortic aneurysm at tertiary hospitals in Spain

    International Angiology, Vol. 40, Núm. 4, pp. 289-296

  2. Follow-up care over 12months of patients with prostate cancer in Spain A multicenter prospective cohort study

    Medicine (United States), Vol. 100, Núm. 47

  3. Meta-analysis of the embryo freezing transfer interval

    Reproductive Medicine and Biology, Vol. 20, Núm. 2, pp. 144-158

  4. Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction models

    Clinical Microbiology and Infection, Vol. 27, Núm. 10, pp. 1422-1430

  5. Reducing unnecessary treatments for acute bronchiolitis through an integrated care pathway

    Pediatrics, Vol. 147, Núm. 6

  6. Telerehabilitation Programme as a Maintenance Strategy for COPD Patients: A 12-Month Randomized Clinical Trial

    Archivos de Bronconeumologia, Vol. 57, Núm. 3, pp. 195-204

  7. Three-dimensional ultrasonography for advanced neurosonography (neurosofe-3D): Validation of a brain volume acquisition guideline

    Acta Obstetricia et Gynecologica Scandinavica, Vol. 100, Núm. 1, pp. 84-90

2020

  1. Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: The DE-imFAR study

    Implementation Science, Vol. 15, Núm. 1